EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | -3.0% | 12,348 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $99 | +7.6% | 12,111 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $92 | -15.6% | 12,720 | +3.5% | 0.00% | 0.0% |
| Q4 2022 | $109 | -99.9% | 12,290 | -23.7% | 0.00% | -66.7% |
| Q3 2022 | $197,000 | +95.0% | 16,099 | +87.8% | 0.01% | +100.0% |
| Q2 2022 | $101,000 | -31.3% | 8,572 | +10.3% | 0.00% | 0.0% |
| Q1 2022 | $147,000 | +129.7% | 7,772 | +398.2% | 0.00% | +200.0% |
| Q3 2021 | $64,000 | -26.4% | 1,560 | +1.0% | 0.00% | -50.0% |
| Q2 2021 | $87,000 | +38.1% | 1,545 | +1.6% | 0.00% | +100.0% |
| Q1 2021 | $63,000 | -37.0% | 1,520 | +6.3% | 0.00% | -50.0% |
| Q4 2020 | $100,000 | +614.3% | 1,430 | +168.8% | 0.00% | +100.0% |
| Q3 2020 | $14,000 | – | 532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |